Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...
November 15, 2017 — Center for Diagnostic Imaging (CDI), one of the nation’s largest providers of diagnostic imaging ...
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
A discussion with William Fearon, M.D. director of interventional cardiology, Stanford University Medical Center, about ...
Philips announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians' use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
Arterys Inc. announced the close of its $30M Series B financing round. The investment was led by Temasek, with strategic investors Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems and GE Ventures, and joined by Fosun, DNA Capital, Emergent Medical Partners and ORI Capital. Arterys plans to use the funding to expand its web-based artificial intelligence (AI) platform, and launch several products in oncology and neurology, and to accelerate the commercialization of its cardiac offering. This new round will enable more radiologists to benefit from artificial intelligence in their daily work.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigator ...
Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital ...
November 10, 2017 — Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Society for Cardiovascular Angiography and Interventions recently announced the launch of TRAnsition for VALUE, a multi-faceted educational initiative supported by Medtronic, to inform cardiologists, hospital administrators and cath lab staff about the benefits of expanding the adoption of transradial (wrist access) percutaneous coronary intervention (PCI) in the U.S.
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now includes two coronary stents — the Tryton Side Branch Stent and Medinol’s NIRxcell, a cobalt-chromium bare metal stent (BMS). Cordis’ cardiology products were on display during the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, Oct. 29-Nov. 2 in Denver.
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican Congress of Cardiology, Nov. 2-5 in Guadalajara, Mexico. The findings create the possibility for patients to receive a pacemaker who otherwise could not afford one.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
To address the specific needs of medical imaging clinical engineering departments nationwide, Siemens Healthineers has introduced Share360, a flexible in-house service portfolio. Leveraging the company’s scalable service infrastructure, Share360 enables customers to select the level of support services and collaboration strategies that best meet the unique requirements of their in-house clinical engineering departments.
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference a new collaboration agreement to increase the clinical availability and adoption of Medis Suite QAngio XA 3D, a proprietary image-based fractional flow reserve (FFR) technology.
A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality ...